First Time Loading...

Prophase Labs Inc
NASDAQ:PRPH

Watchlist Manager
Prophase Labs Inc Logo
Prophase Labs Inc
NASDAQ:PRPH
Watchlist
Price: 5.42 USD 2.07% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

PRPH Price Targets Summary
Prophase Labs Inc

Wall Street analysts forecast PRPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRPH is 21.42 USD with a low forecast of 21.21 USD and a high forecast of 22.05 USD.

PRPH Lowest Forecast
Wall Street Target
21.21 USD
291% Upside
PRPH Average Forecast
Wall Street Target
21.42 USD
295% Upside
PRPH Highest Forecast
Wall Street Target
22.05 USD
307% Upside
Lowest
Price Target
21.21 USD
291% Upside
Average
Price Target
21.42 USD
295% Upside
Highest
Price Target
22.05 USD
307% Upside
Prophase Labs Inc Competitors:
Price Targets
I
ITCI
Intra-Cellular Therapies Inc
36% Upside
CARA
Cara Therapeutics Inc
552% Upside
G
GTII
Green Thumb Industries Inc
42% Upside
S
4565
Sosei Group Corp
51% Upside
I
ITCI
Intra-Cellular Therapies Inc
36% Upside
CARA
Cara Therapeutics Inc
552% Upside
G
GTII
Green Thumb Industries Inc
42% Upside
S
4565
Sosei Group Corp
51% Upside
688526
Wuhan Keqian Biology Co Ltd
50% Upside
GLAND
Gland Pharma Ltd
9% Upside
460
Sihuan Pharmaceutical Holdings Group Ltd
349% Upside
4746
Formosa Laboratories Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Prophase Labs Inc

For the last 8 years the compound annual growth rate for Prophase Labs Inc's revenue is 43%. The projected CAGR for the next 2 years is 74%.

43%
Past Growth
74%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Prophase Labs Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Prophase Labs Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
PRPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRPH stock valuation using valuation multiples.
Wall Street Estimates
PRPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRPH's stock price target?
Price Target
21.42 USD

According to Wall Street analysts, the average 1-year price target for PRPH is 21.42 USD with a low forecast of 21.21 USD and a high forecast of 22.05 USD.

What is Prophase Labs Inc's Revenue forecast?
Projected CAGR
74%

For the last 8 years the compound annual growth rate for Prophase Labs Inc's revenue is 43%. The projected CAGR for the next 2 years is 74%.

ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.